These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 19810171

  • 41. In vitro activity of BMY-28142, a new cephalosporin.
    Norden CW, Neiderriter K.
    Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
    [Abstract] [Full Text] [Related]

  • 42. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P, Oppenheim BA, Skepastianos P, Livermore DM, Williams RJ.
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [Abstract] [Full Text] [Related]

  • 43. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
    Dabernat HJ, Delmas C.
    Rev Infect Dis; 1982 Dec; 4 Suppl():S401-5. PubMed ID: 6294790
    [Abstract] [Full Text] [Related]

  • 44. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 45. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C, Lesage D, Delisle-Mizon F, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
    [Abstract] [Full Text] [Related]

  • 46. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
    Jones RN, Erwin ME, Barrett MS, Johnson DM, Briggs BM.
    Diagn Microbiol Infect Dis; 1991 May; 14(4):301-9. PubMed ID: 1889181
    [Abstract] [Full Text] [Related]

  • 47. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA, Day GJ, Humble MW.
    N Z Med J; 1982 Jun 23; 95(710):414-6. PubMed ID: 6810246
    [Abstract] [Full Text] [Related]

  • 48. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P, Robert J, Le Noc D.
    Pathol Biol (Paris); 1984 May 23; 32(5):404-7. PubMed ID: 6429611
    [Abstract] [Full Text] [Related]

  • 49. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP, Bongaerts GP, van Gestel MH.
    J Antimicrob Chemother; 1981 Sep 23; 8 Suppl B():147-52. PubMed ID: 19802978
    [Abstract] [Full Text] [Related]

  • 50. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R, Gordts B, Coignau H, Stas G, Butzler JP.
    J Antimicrob Chemother; 1981 Sep 23; 8 Suppl B():63-6. PubMed ID: 19802970
    [Abstract] [Full Text] [Related]

  • 51. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D, Delisle-Mizon F, Denis C, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1982 Jun 23; 30(6):440-3. PubMed ID: 6213917
    [Abstract] [Full Text] [Related]

  • 52. Ro 13-9904 and GR 20263, two new cephalosporins with broad-spectrum activity: an in vitro comparison with other beta-lactam antibiotics.
    Clarke AM, Zemcov SJ.
    J Antimicrob Chemother; 1981 May 23; 7(5):515-20. PubMed ID: 6790506
    [No Abstract] [Full Text] [Related]

  • 53. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX, Zhang YX, Neu HC.
    Diagn Microbiol Infect Dis; 1991 May 23; 14(5):417-24. PubMed ID: 1797456
    [Abstract] [Full Text] [Related]

  • 54. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A, Meyran M, Huerre M.
    Pathol Biol (Paris); 1985 May 23; 33(5):404-7. PubMed ID: 3929217
    [Abstract] [Full Text] [Related]

  • 55. In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.
    Tsuji A, Maniatis A, Bertram MA, Young LS.
    Antimicrob Agents Chemother; 1985 Apr 23; 27(4):515-9. PubMed ID: 3839120
    [Abstract] [Full Text] [Related]

  • 56. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA, Cuffini AM, Forno-Pizzoglio M, Aragno M.
    G Batteriol Virol Immunol; 1983 Apr 23; 76(7-12):246-56. PubMed ID: 6099297
    [Abstract] [Full Text] [Related]

  • 57. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
    Goldstein EJ, Citron DM.
    Antimicrob Agents Chemother; 1985 Jul 23; 28(1):160-2. PubMed ID: 3929677
    [Abstract] [Full Text] [Related]

  • 58. Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.
    Thornsberry C.
    Am J Med; 1985 Aug 09; 79(2A):14-20. PubMed ID: 3927723
    [Abstract] [Full Text] [Related]

  • 59. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS, Neu HC.
    Antimicrob Agents Chemother; 1981 Oct 09; 20(4):545-6. PubMed ID: 6282199
    [Abstract] [Full Text] [Related]

  • 60. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Oct 09; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.